Tag: equity
-
Venture Deals, Dollars Fall in Q4 2019; Biotech Stays Hot
Venture capital deal-making in the U.S. declined in the fourth quarter of 2019, but biotechnology start-ups remained the most sought-after investment targets of any sector.
-
UPMC to Invest $1 Billion in Medical Enterprises
UPMC, the medical center affiliated with University of Pittsburgh, plans to invest $1 billion in life science advances, with spin-off companies as part of its strategy.
-
New Biotech Aims to Bring Down Drug Prices
A biotechnology company launched yesterday that plans to discover and develop therapies faster and at lower cost than many of today’s new drugs.
-
Vaccine Developer Gains $11M in Early Funds
A company designing vaccines delivered with a microneedle patch to prevent infectious diseases is raising $11 million in its first venture funding round.
-
Infographic – Biotech Index Zooms to New High
Since October, the Nasdaq Biotechnology Index rose steadily to a new high for the year, as shown in this weekend’s infographic.
-
Synthetic Bio Cancer Immunotherapy Company Acquired
A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma.
-
Touch Sensor Developer Gains $12M in Early Funds
A company making gloves that transmit a sense of touch in games and commercial robotics is raising $12 million in its first venture funding round.
-
Engineered Viruses Licensed for Cancer Therapies
A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals.
-
Synthetic Bio Company Acquired in $2.35B Deal
A company developing protein-like therapies for cancer from synthetic bacteria is being acquired by drug maker Sanofi in a deal valued at $2.35 billion.
-
Radiology A.I. Company Raises $4M in Seed Funds
A start-up company developing systems with artificial intelligence to aid the work of radiologists is raising $4 million in its seed funding round.